LI/NEI Repository Protocol

目的：本方案将允许对使用人体样本和根据其他分支方案收集的数据的研究进行前瞻性IRB审查。

Objective: This protocol will enable prospective IRB review of research using human samples and data collected under other branch protocols. Study population: Participants that were followed in terminated branch protocols under which data or samples were collected. Design: Samples and data will be brought under this protocol, analyzed and stored for uses specified in the original protocols and as additionally approved by the IRB. Outcome: The outcome of this protocol will be the storage, tracking, and utilization of samples and data obtained under terminated protocols. Data and samples will enter this protocol from terminated IRB-approved protocols under which all human participant enrollment and participation is complete including: Protocol 04-EI-0065 (SCL31 Levy-Clarke) Protocol 96-EI-0096 (HAT Nussenblatt) Protocol 06-EI-0239 (Sarcoidosis Levy-Clarke) Protocol 02-EI-0099 (Microarray Nussenblatt) Protocol 05-EI-0178 (SITE Nussenblatt) Protocol 05-EI-0208 (HAT/JIA Nussenblatt) Protocol 00-EI-0204 (Uveitis ENT Nussenblatt) Protocol 98-EI-0085 (Uveitis Screening Nussenblatt) Protocol 04-EI-0260 (Uveitis Marker) Protocol 06-EI-0046 (Anti-CD11 Nussenblatt) Protocol 06-EI-0111 (AMDB1 Nussenblatt) Protocol 09-EI-0191 (JakStat Sen) Protocol 09-EI-0116 (SIRANU Sen) Protocol 10-EI-0186 (MIME Sen) Protocol 11-EI-0167 (JakStat 2 Sen) Protocol 11-EI-0107 (MEXX Sen) Protocol 10-EI-0191 (BOOTS Nussenblatt) Protocol 10-EI-0040 (RAIR Sen) Protocol 12-EI-0057 (ISAS Sen) Protocol 92-EI-0113 (Tissue Nussenblatt) Protocol 03-EI-0155 (SNPS Nussenblatt) Protocol 13-EI-0102 (GATSBY Sen)